Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Other3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT05137860Phase 4Unknown
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Acute Lymphoblastic Leukemia, in RelapseChemotherapeutic ToxicityMinimal Residual Disease
StudydirectorStart date: 2021-12-12
NCT05133310Phase 4Unknown
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaSepsisStrains
StudydirectorStart date: 2021-11-19
NCT05059847Not ApplicableUnknown
Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults
Acute Lymphoblastic Leukemia, Adult B-Cell
StudydirectorStart date: 2021-09-06

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05137860Phase 4StudyDirector

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Acute Lymphoblastic Leukemia, in RelapseChemotherapeutic ToxicityMinimal Residual Disease
Unknown
NCT05133310Phase 4StudyDirector

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic LeukemiaSepsisStrains
Unknown
NCT05059847Not ApplicableStudyDirector

Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults

Acute Lymphoblastic Leukemia, Adult B-Cell
Unknown

All 3 trials loaded